152 related articles for article (PubMed ID: 2477079)
1. Enrichment of two glycosyl-phosphatidylinositol-anchored proteins, acetylcholinesterase and decay accelerating factor, in vesicles released from human red blood cells.
Bütikofer P; Kuypers FA; Xu CM; Chiu DT; Lubin B
Blood; 1989 Oct; 74(5):1481-5. PubMed ID: 2477079
[TBL] [Abstract][Full Text] [Related]
2. Cells lacking glycan phosphatidylinositol-linked proteins have impaired ability to vesiculate.
Whitlow M; Iida K; Marshall P; Silber R; Nussenzweig V
Blood; 1993 Jan; 81(2):510-6. PubMed ID: 7678519
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of glycosyl-phosphatidylinositol anchored proteins on paroxysmal nocturnal haemoglobinuria (PNH) neutrophils and monocytes: heterogeneous deficiency of decay-accelerating factor (DAF) and CD16 on PNH neutrophils.
Kawakami Z; Ninomiya H; Tomiyama J; Abe T
Br J Haematol; 1990 Apr; 74(4):508-13. PubMed ID: 1693286
[TBL] [Abstract][Full Text] [Related]
4. In vitro incorporation of GPI-anchored proteins into human erythrocytes and their fate in the membrane.
Civenni G; Test ST; Brodbeck U; Bütikofer P
Blood; 1998 Mar; 91(5):1784-92. PubMed ID: 9473247
[TBL] [Abstract][Full Text] [Related]
5. Effect of glycoinositolphospholipid anchor lipid groups on functional properties of decay-accelerating factor protein in cells.
Walter EI; Ratnoff WD; Long KE; Kazura JW; Medof ME
J Biol Chem; 1992 Jan; 267(2):1245-52. PubMed ID: 1370460
[TBL] [Abstract][Full Text] [Related]
6. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
Lublin DM; Coyne KE
J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
[TBL] [Abstract][Full Text] [Related]
7. In vitro attachment of glycosyl-inositolphospholipid anchor structures to mouse Thy-1 antigen and human decay-accelerating factor.
Fasel N; Rousseaux M; Schaerer E; Medof ME; Tykocinski ML; Bron C
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):6858-62. PubMed ID: 2476803
[TBL] [Abstract][Full Text] [Related]
8. Glycosyl phosphatidylinositol-linked blood group antigens and paroxysmal nocturnal hemoglobinuria.
Telen MJ
Transfus Clin Biol; 1995; 2(4):277-90. PubMed ID: 8542026
[TBL] [Abstract][Full Text] [Related]
9. On the mechanism of red blood cell shape change and release of spectrin-free vesicles.
Müller H; Schmidt U; Lutz HU
Acta Biol Med Ger; 1981; 40(4-5):413-7. PubMed ID: 6274111
[TBL] [Abstract][Full Text] [Related]
10. An internally positioned signal can direct attachment of a glycophospholipid membrane anchor.
Caras IW
J Cell Biol; 1991 Apr; 113(1):77-85. PubMed ID: 1706725
[TBL] [Abstract][Full Text] [Related]
11. Shaping the too fluid bilayer.
Morrow JS; Anderson RA
Lab Invest; 1986 Mar; 54(3):237-40. PubMed ID: 3005766
[No Abstract] [Full Text] [Related]
12. Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.
Davitz MA; Low MG; Nussenzweig V
J Exp Med; 1986 May; 163(5):1150-61. PubMed ID: 2422313
[TBL] [Abstract][Full Text] [Related]
13. The Inab phenotype: characterization of the membrane protein and complement regulatory defect.
Telen MJ; Green AM
Blood; 1989 Jul; 74(1):437-41. PubMed ID: 2473800
[TBL] [Abstract][Full Text] [Related]
14. Robust in vitro replication of Plasmodium falciparum in glycosyl-phosphatidylinositol-anchored membrane glycoprotein-deficient red blood cells.
Pattanapanyasat K; Walsh DS; Yongvanitchit K; Piyawatthanasakul N; Wanachiwanawin W; Webster HK
Am J Trop Med Hyg; 2003 Oct; 69(4):360-5. PubMed ID: 14640493
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol-glycan linked proteins of the erythrocyte membrane.
Telen MJ; Rosse WF
Baillieres Clin Haematol; 1991 Dec; 4(4):849-68. PubMed ID: 1724205
[TBL] [Abstract][Full Text] [Related]
16. A nonfunctional sequence converted to a signal for glycophosphatidylinositol membrane anchor attachment.
Moran P; Caras IW
J Cell Biol; 1991 Oct; 115(2):329-36. PubMed ID: 1717483
[TBL] [Abstract][Full Text] [Related]
17. Release of vesicles enriched in complement receptor 1 from human erythrocytes.
Pascual M; Lutz HU; Steiger G; Stammler P; Schifferli JA
J Immunol; 1993 Jul; 151(1):397-404. PubMed ID: 8326133
[TBL] [Abstract][Full Text] [Related]
18. Chlorpromazine inhibits vesiculation, alters phosphoinositide turnover and changes deformability of ATP-depleted RBCs.
Bütikofer P; Lin ZW; Kuypers FA; Scott MD; Xu CM; Wagner GM; Chiu DT; Lubin B
Blood; 1989 May; 73(6):1699-704. PubMed ID: 2540856
[TBL] [Abstract][Full Text] [Related]
19. A glycophospholipid membrane anchor acts as an apical targeting signal in polarized epithelial cells.
Lisanti MP; Caras IW; Davitz MA; Rodriguez-Boulan E
J Cell Biol; 1989 Nov; 109(5):2145-56. PubMed ID: 2478564
[TBL] [Abstract][Full Text] [Related]
20. Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
Edberg JC; Salmon JE; Whitlow M; Kimberly RP
J Clin Invest; 1991 Jan; 87(1):58-67. PubMed ID: 1702101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
